🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/10/1990 | 12,84 | 13,08 | 12,82 | 13,02 | +0,61% | 2,01% | 3.477.893 |
| 23/10/1990 | 13,00 | 13,12 | 12,82 | 12,94 | -1,06% | 2,29% | 4.284.014 |
| 22/10/1990 | 12,82 | 13,08 | 12,76 | 13,08 | +1,86% | 2,48% | 6.482.928 |
| 19/10/1990 | 12,88 | 12,88 | 12,62 | 12,84 | +0,78% | 2,01% | 11.652.922 |
| 18/10/1990 | 12,60 | 12,76 | 12,52 | 12,74 | +2,07% | 1,89% | 5.505.773 |
| 17/10/1990 | 12,40 | 12,54 | 12,38 | 12,48 | +0,80% | 1,28% | 3.511.219 |
| 16/10/1990 | 12,46 | 12,52 | 12,31 | 12,38 | -0,80% | 1,75% | 3.991.622 |
| 15/10/1990 | 12,40 | 12,56 | 12,17 | 12,48 | +1,62% | 3,21% | 5.588.146 |
| 12/10/1990 | 12,09 | 12,34 | 11,97 | 12,29 | +2,66% | 3,12% | 7.033.757 |
| 11/10/1990 | 12,07 | 12,17 | 11,89 | 11,97 | -0,99% | 2,31% | 7.414.181 |
| 10/10/1990 | 12,01 | 12,36 | 11,91 | 12,09 | +1,16% | 3,81% | 8.647.258 |
| 09/10/1990 | 12,33 | 12,36 | 11,93 | 11,95 | -4,15% | 3,55% | 5.197.661 |
| 08/10/1990 | 12,48 | 12,58 | 12,40 | 12,46 | +0,64% | 1,43% | 2.281.286 |
| 05/10/1990 | 12,29 | 12,58 | 12,21 | 12,38 | -0,80% | 3,07% | 7.279.618 |
| 04/10/1990 | 12,48 | 12,54 | 12,38 | 12,48 | -0,16% | 1,27% | 4.513.526 |
| 03/10/1990 | 12,60 | 12,62 | 12,42 | 12,50 | -0,79% | 1,58% | 4.385.251 |
| 02/10/1990 | 12,84 | 12,86 | 12,60 | 12,60 | -1,25% | 2,01% | 7.397.203 |
| 01/10/1990 | 12,25 | 12,78 | 12,23 | 12,76 | +5,42% | 4,55% | 9.055.978 |
| 28/09/1990 | 11,67 | 12,11 | 11,51 | 12,11 | +3,92% | 5,11% | 6.459.034 |
| 27/09/1990 | 11,93 | 11,93 | 11,61 | 11,65 | -1,18% | 2,67% | 5.449.810 |
| 26/09/1990 | 11,95 | 11,99 | 11,73 | 11,79 | -1,33% | 2,16% | 4.578.293 |
| 25/09/1990 | 11,71 | 11,97 | 11,69 | 11,95 | +2,04% | 2,38% | 4.412.918 |
| 24/09/1990 | 12,01 | 12,01 | 11,69 | 11,71 | -2,64% | 2,65% | 4.953.058 |
| 21/09/1990 | 12,05 | 12,13 | 11,95 | 12,03 | -0,17% | 1,49% | 8.938.392 |
| 20/09/1990 | 12,23 | 12,23 | 11,95 | 12,05 | -1,46% | 2,28% | 6.266.621 |
| 19/09/1990 | 12,09 | 12,31 | 12,09 | 12,23 | -3,91% | 1,81% | 18.291.163 |
| 18/09/1990 | 12,70 | 12,80 | 12,56 | 12,72 | -0,16% | 1,88% | 4.813.464 |
| 17/09/1990 | 12,68 | 12,76 | 12,56 | 12,74 | -0,16% | 1,57% | 3.506.818 |
| 14/09/1990 | 12,68 | 12,76 | 12,62 | 12,76 | +0,31% | 1,10% | 4.028.093 |
| 13/09/1990 | 12,90 | 12,98 | 12,72 | 12,72 | -1,39% | 2,00% | 2.876.131 |